We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£515.00
It has never been this cheap. We have no record of a lower price.
£515 today · cheaper than every other day in the last 3 months
Glioblastoma Multiforme Drug Outlook India 2023-2028
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 14 days · 14 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 14 days • 1 price levels
Price Analysis
Most common price: £515 (14 days, 100.0%)
Price range: £515 - £515
Price levels: 1 different prices over 14 days
Description
Key Features
Provides latent demand estimates in millions of U.S. dollars for Glioblastoma Multiforme drugs across India.
Includes potential industry earnings (P.I.E.) data for more than 4,900 cities throughout the country.
Offers comparative benchmarks by reporting the percent share of each city relative to its state and union territory.
Supports distribution and sales force strategies through detailed city-level and national market share reporting.
Covers a comprehensive outlook period from 2023 to 2028 for the Indian pharmaceutical market.
Product Specifications
- Format
- paperback
- ASIN
- B0BGKZD3PP
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 14 September 2022
- Listed Since
- 28 September 2022
Similar Products You Might Like
The 2023-2028 Outlook for Glioblastoma Multiforme Drugs in China
Brain Tumor Diagnosis and Treatment Outlook in India 2023-2028
Primary Brain Tumor Diagnosis and Treatment Outlook in India
Brain Tumor Diagnosis and Treatments Outlook 2023-2028
Primary Brain Tumor Diagnosis and Treatment Outlook 2023-2028
The 2023 Report on Primary Brain Tumor Diagnosis and Treatments: World Market Segmentation by City
Non-Hodgkin Lymphoma Outlook in India 2023-2028 Study
Non-Hodgkin Lymphoma Chemotherapy Outlook in India 2023-2028
Glioblastoma - New Solutions for Brain Cancerogenesis (Oncology)
IntechOpen
The 2023 Report on Cell-Based Brain Tumor Therapeutics: World Market Segmentation by City
Non-Hodgkin Lymphoma Chemotherapy Outlook 2023-2028 Study
Non-Hodgkin Lymphoma Outlook 2023-2028 - US Market Study
Glioblastoma: Methods and Protocols: 1741 (Methods in Molecular Biology, 1741)
Humana
The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in China
The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in China
Non-Hodgkin Lymphoma Treatment Outlook 2023-2028 Report
The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in Japan
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in Japan
The 2023-2028 World Outlook for Brain Tumor Diagnosis and Treatments
Price unavailable
Genetic and Epigenetic Alterations in Patients with Malignant Glioma
LAP Lambert Academic Publishing
Non-Hodgkin's and Chronic Lymphoma Market Outlook in India
Novel Therapeutic Concepts in Targeting Glioma - Medical
IntechOpen